Sunday, 22 May 2022


Japan approves MicroPort CRM's Alizea Bluetooth Pacemaker

17 January 2022 | News

Alizea pacemakers allow cardiologists to monitor devices remotely

image credit- prnewswire

image credit- prnewswire

MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, has recently received Pharmaceuticals and Medical Devices Agency (PMDA) Japanese regulation agency approval for its latest range of implantable pacemakers, Alizea.

The devices are equipped with Bluetooth technology for streamlined remote monitoring when paired with MicroPort CRM's SmartView Connect home monitor, already approved in Japan. 

Alizea pacemakers allow cardiologists to monitor devices remotely. The SmartView Connect home monitor is designed to be placed at the patient's bedside to allow for the regular transmission of detailed reports to the cardiologist on the functioning of the pacing system, removing the need for patients to visit the hospital for simple routine examinations, and thus reducing the burden on the healthcare system.

Alizea pacemakers and the SmartView Connect home monitor work together to provide the cardiologist with timely alerts and transmissions triggered by patients when they present symptoms, leading to faster and more efficient patient care.

Noboru Shimizu, VP of MicroPort CRM Sales Japan, commented, "Around 64,000 patients are implanted with a pacemaker each year in Japan, and coupled with the difficulties that have arisen from the current health crisis, there is a growing need to monitor patients remotely, without them having to travel."

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account